Global or regional partnershipsGiven that CTAs will be sought in Japan, Europe, Canada and Australia, PLI has set this up to strike a global partnership on IPF with a Big Pharma. If PLI decides to keep the North American market for itself then regional partnerships in Japan, Europe and Australia could be in the making. No doubt it is going to be interesting to see which route PLI takes. At least the regulatory pathway is now absolutely clear. Let the negotiations get fast tracked so deals are announced before year end:-)